The goal of this Phase II project is to optimize and validate a microfluidic chip-based process that automates and shortens the labeling, washing and collecting of human blood leukocytes (WBCs) for flow cytometric analysis of clinically important cell-surface and intracellular markers. Multi-parameter flow cytometry is an increasingly powerful and widely used technology in research and in clinical diagnostic testing for cancer and many other diseases. There is a critical need for new methods to improve the efficiency of sample preparation, which is laborious and variable and typically requires many cycles of washing collecting cells by centrifugation. GPB LLC is developing a novel microfluidic Deterministic Lateral Displacement (DLD) chip processing technology that can harvest cells from a flow of fluid on the basis of size. A mixture of fluid and particles flows through an array f microposts that are tilted at a small angle from the direction of the fluid flow. Cells within the target size range are deflected off the microposts in a process that is rapid yet gentle. The novel disposable DLD chips will allow automation and potentially combination of the processes of labeling, fixing and washing cells from very small samples of whole blood. The Phase I STTR project, a collaboration among GPB, Princeton University and the University of Maryland (UM), successfully demonstrated proof of principle by showing that prototype DLD chips can harvest monoclonal antibody (Mab)-labeled WBCs from human whole blood with high cell recovery and viability while removing the large excess of red blood cells (RBCs) and unbound Mab, and without skewing the distribution of WBC subsets. The objective of this Phase II project is to optimize a suite of DLD chips and processes as prototype commercial products.
Aim 1 is to design and optimize DLD chip-based systems for washing and concentrating human blood WBCs.
Aim 2 is to design and validate DLD chip-based systems for surface labeling, on-chip fixation-permeabilization, or intracellular labeling of WBCs, combined with on-chip washing.
Aim 3 is to develop a DLD chip-based system to fix, permeabilize, intracellularly label, wash, and concentrate WBCs on a single chip.
Aim 4 is to produce prototype application-specific chips and an automated platform product to control WBC processing via a user interface. Cell labeling will be tested with panels of Mab reagents and cocktails that are commonly used for cell surface labeling and for intracellular labeling in clinical diagnostic, prognostic and research testing. Outcomes will be measured by flow cytometry in several laboratories at UM, GBP and several collaborating large diagnostic companies. Some of these companies have expressed interest in helping to commercialize chip and processing system products.

Public Health Relevance

Flow cytometry for single-cell analysis is a widely used analytical method for research, clinical diagnosis and treatment monitor, but the multi-step cell staining protocols are manual, tedious and fraught with variability. The novel GPB novel microfluidic technology platform will simplify, automate, and reduce the cost of the cell processing steps and decrease sample variability. Successful completion of this Phase II project will result in a suite of products that will start with whole blood and generate purified WBC samples that are ready for flow cytometric analysis. Moreover, these products also will facilitate sample preparation for other powerful new technologies such as mass cytometry, rare cell isolation, single cell genomics, proteomics, metabolomics and a wide range of new techniques under development.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Technology Transfer (STTR) Grants - Phase II (R42)
Project #
2R42CA174121-02
Application #
8903187
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Lou, Xing-Jian
Project Start
2012-09-24
Project End
2017-04-30
Budget Start
2015-05-18
Budget End
2016-04-30
Support Year
2
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Gpb Scientific, LLC
Department
Type
DUNS #
832526581
City
Richmond
State
VA
Country
United States
Zip Code
23219
Chen, Yu; Austin, Robert H; Sturm, James C (2017) On-chip cell labelling and washing by capture and release using microfluidic trap arrays. Biomicrofluidics 11:054107
Civin, Curt I; Ward, Tony; Skelley, Alison M et al. (2016) Automated leukocyte processing by microfluidic deterministic lateral displacement. Cytometry A 89:1073-1083
Chen, Yu; D'Silva, Joseph; Austin, Robert H et al. (2015) Microfluidic chemical processing with on-chip washing by deterministic lateral displacement arrays with separator walls. Biomicrofluidics 9:054105